When traditional methods like diet and exercise arent enough, many people look toward medical interventions like Wegovy (semaglutide) or phentermine
GSH has limited permeability through the blood-brain barrier(Haddad et al., 2021), a systemic isolation which might contribute to the stability of cerebral GSH levels with pathology(Haddad et al., 2021) and aging(Gong et al., 2022
That points to a third strength: the system sees drugs not in isolation, but in combination
In conjunction with the rising prevalence, the cost is expected to rise to a staggering 958 billion USD by 2045 [6,7,8,9]
Moreover, because the TMD is less accessible than the extracellular region, this approach may facilitate the design of peptide ligands with moderate binding to better distinguish between target cells and nontarget cells